Federal Vaccine Guidance Stalls as Major Physician Societies Issue Independent Recommendations
During the 2024-2025 winter season, roughly 100,000 Americans died from seasonal respiratory viruses, including 45,000 from influenza, 45,000 from COVID-19, and 10,000 from RSV, according to Centers for Disease Control and Prevention estimates. This fall, the federal vaccine process has broken down because the Advisory Committee on Immunization Practices hasn’t met since last December. Consequently, the CDC posted interim guidance for flu and COVID-19 vaccinations that remains roughly unchanged from last year. Massachusetts and other states subsequently issued guidance based on that same work. While medical societies can review evidence and guide doctors, they cannot perform core federal functions such as running national vaccination campaigns, giving recommendations legal force for insurance coverage, or buying and distributing millions of vaccine doses.
Coordinated Medical Society Recommendations Replace Absent Federal Leadership
Medical societies stepped forward in September to issue joint recommendations because federal guidance stalled. These organizations lack the infrastructure to run national immunization campaigns or purchase vaccine supplies. States like Massachusetts adapted their guidance from the physician societies’ review, but local adoption cannot fully replace centralized federal distribution and legal mandates.
Vaccine Schedules and Patient Recommendations for Flu, COVID, and RSV
Adults aged 65 and older should receive one of the three preferentially recommended versions—high-dose, adjuvanted, or recombinant—when available. Because efficacy wanes over time, optimal protection for the spring is achieved by getting vaccinated around Halloween. For COVID-19, the FDA approved updated vaccines in late August for adults 65 and older and younger people with high-risk conditions, while healthy younger adults can still receive them off-label. High-risk individuals should get vaccinated, while vaccination for everyone else remains a judgment call. Pediatricians recommend the COVID-19 vaccine for all children aged 6 to 23 months without contraindications, while high-risk children should definitely be vaccinated. For RSV, the immunization is a single dose rather than an annual routine. It is recommended once for adults 75 and older, adults aged 50 to 74 at higher risk, and immunocompromised adults and adolescents. Infants are protected either by vaccinating the mother at 32 to 36 weeks of pregnancy or by giving the newborn an antibody shot after birth.
Employer Plans and Federal Programs Create Vaccine Coverage Gaps
For most adults, vaccines are available and free. Major insurers have pledged to cover them without cost-sharing through 2027, and Massachusetts requires state-regulated insurers to cover recommendations from its public health department. However, self-funded employer plans, covering roughly two-thirds of workers with job-based insurance, fall outside both protections. Most employers cover their employees, but coverage varies.
Children face separate distribution hurdles. About half of American children are eligible for vaccines through the Vaccines for Children program, which serves those who are uninsured, underinsured, on Medicaid, or American Indian or Alaska Native. The CDC left the program in limbo for nearly a month after FDA approval before finally opening orders for updated COVID-19 vaccines. During this gap, privately insured children could get vaccinated while children relying on the federal program could not, leaving high-risk children unprotected while viruses spread. Vaccine availability now varies by state based on how quickly local agencies process new orders.
Frequently Asked Questions
When should older adults receive their influenza vaccine for optimal protection?
For individuals who have not yet been vaccinated, health experts recommend getting the shot around Halloween to ensure optimal protection lasting into the spring when the flu season wanes.
Who is eligible to receive the single-dose RSV vaccine?
The RSV vaccine is recommended as a single lifetime dose for adults 75 and older, adults aged 50 to 74 who are at higher risk, and immunocompromised adults and adolescents of any age.
How do infants receive protection against RSV under current guidelines?
Infants receive protection through one of two routes: either by vaccinating the mother between 32 and 36 weeks of pregnancy or by administering an antibody shot to the newborn directly after birth.
Keep reading